3 of the best ASX shares to buy this month

Afterpay Ltd (ASX:APT) and these ASX shares could be quality options for investors in April. Here’s what you need to know about them…

| More on:
boy in celebration pose with pointed fingers raised high

Image source: Getty Images

If you’re looking to add some new shares to your portfolio in April, then you might want to take a look at the ones listed below.

They could be among the best on the market and destined to deliver strong growth over the 2020s. Here’s why they are rated highly:

Afterpay Ltd (ASX: APT)

The first ASX share to consider is Afterpay. Due to the increasing popularity of its buy now pay later platform and its global expansion, the payments company looks exceptionally well-positioned for growth over the 2020s. In respect to its expansion, Afterpay has just launched in Canada, is launching in mainland Europe shortly, and is looking closely at the Asia market. Combined with its $5 trillion opportunity in the United States, the future looks bright for the company.

Morgan Stanley currently has an overweight rating and $149.00 price target on its shares.

Pushpay Holdings Group Ltd (ASX: PPH)

Another ASX share to consider buying is Pushpay. It is a donor management and community engagement platform provider for the faith sector. Thanks to the shift to a cashless society and social distancing measures, Pushpay’s platform is proving invaluable for churches. This has led to it delivering stellar sales growth over the last few years. And thanks to operating leverage, its earnings have been growing at an even quicker rate.

Goldman Sachs is a fan of Pushpay and has a conviction buy rating and $2.59 price target on its shares.

ResMed Inc. (ASX: RMD)

A final ASX share to consider is ResMed. This sleep treatment-focused medical device company appears well-placed for growth thanks to its industry-leading products and sizeable market opportunity. ResMed also has a growing ecosystem of connected devices generating invaluable data insights. This could give it a real edge over the competition in the future and puts it in a great position to benefit from the shift to home healthcare.

Bell Potter is positive on ResMed’s outlook. It currently has a buy rating and $29.00 price target on its shares.

Wondering where you should invest $1,000 right now?

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

Scott just revealed what he believes could be the five best ASX stocks for investors to buy right now. These stocks are trading at near dirt-cheap prices and Scott thinks they could be great buys right now.

*Returns as of August 16th 2021

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. owns shares of PUSHPAY FPO NZX. The Motley Fool Australia owns shares of AFTERPAY T FPO. The Motley Fool Australia has recommended PUSHPAY FPO NZX and ResMed Inc. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Growth Shares